Neurogene (NGNE) Prepaid Assets (2013 - 2026)
Neurogene's (NGNE) quarterly Prepaid Assets came in at $181000.0 in Q1 2026, down 95.23% YoY from $3.8 million in Q1 2025, and down 93.43% on a QoQ basis from $2.8 million in Q4 2025.
Analysis
Neurogene (NGNE) Prepaid Assets (2013 - 2026) Analysis & Trends
Neurogene (NGNE) has 10 years of Prepaid Assets data on file, last reported at $181000.0 in Q1 2026.
- Quarterly Prepaid Assets fell 95.23% year-over-year to $181000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $181000.0 (down 95.23% YoY) and the FY2025 annual result came in at $2.8 million, up 181.04% from the prior year.
- Prepaid Assets eased to $181000.0 in Q1 2026, from $2.8 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $4.7 million in Q3 2024 to a low of $181000.0 in Q1 2026.
- A 5-year average of $2.0 million and a median of $2.0 million in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets surged 235.79% — and 2025, when it plunged 95.53%.
- Tracing NGNE's Prepaid Assets over 5 years: stood at $2.7 million in 2022, then gained by 18.27% to $3.2 million in 2023, then sank by 69.26% to $981000.0 in 2024, then jumped by 181.04% to $2.8 million in 2025, then plunged by 93.43% to $181000.0 in 2026.
- The last three Prepaid Assets figures came in at $181000.0 (Q1 2026), $2.8 million (Q4 2025), and $208000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Neurogene | 864.53 Mn | 864.53 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.52 Mn |
| Mar 31, 2026 | 3.57 Mn |
| Dec 31, 2025 | 2.76 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Jun 30, 2025 | 4.47 Mn |
| Mar 31, 2025 | 3.80 Mn |
| Dec 31, 2024 | 3.52 Mn |
| Sep 30, 2024 | 4.65 Mn |
| Jun 30, 2024 | 5.24 Mn |
| Mar 31, 2024 | 4.61 Mn |
| Dec 31, 2023 | 3.19 Mn |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 1.72 Mn |
| Mar 31, 2023 | 2.20 Mn |
| Dec 31, 2022 | 2.70 Mn |
| Sep 30, 2022 | 1.98 Mn |
| Jun 30, 2022 | 2.03 Mn |
| Mar 31, 2022 | 2.31 Mn |
| Dec 31, 2021 | 1.52 Mn |
| Sep 30, 2021 | 1.57 Mn |